<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>Full STD Guidelines</title>

        <link href="../jquery-mobile/jquery.mobile.theme-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.j.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.8.2.min.js" type="text/javascript"></script>
        <script src="../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.2.0.min.js" type="text/javascript"></script>
        <script src="../cordova-2.2.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>

    </head>
    <body>

        <!-- Start of page -->
        <div data-role="page" id="heading_page_300" data-theme="d">
            <div data-role="header" data-id="guidelines-header" data-theme="j" data-position="fixed">
                <a href="lv-300.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>Full STD Guidelines</h1>
	            <a href="../menu.html"  rel="external" data-role="button" data-theme="reset" data-transition="fade" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>  <!-- end of header div -->

            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-297.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-299.html" >Pelvic Inflammatory Disease</a><span class="carrot"> > </span>
                    <a href="lv-300.html" >Treatment</a><span class="carrot"> > </span>
                    <a href="lv-300.html" >Parenteral Treatment</a><span class="carrot"> > </span>Overview
            </div>   <!-- end of guidelines listview breadcrumbs -->
            </br><h3 class="sgc-1" id="sigil_toc_id_300">
 Parenteral Treatment
</h3>
<p>
 For women with PID of mild or moderate severity, parenteral&nbsp;and oral therapies appear to have similar clinical efficacy. Many randomized trials have demonstrated the efficacy of both parenteral and oral regimens (390,391,393). Clinical experience&nbsp;should guide decisions regarding transition to oral therapy, which usually can be initiated within 24&ndash;48 hours of clinical improvement. In women with tubo-ovarian abscesses, at least 24 hours of direct inpatient observation is recommended.
</p>
<p>


        <!--- Regimens Table below is generated from Python script.  --->
        <div id="table">
            <div id="regimen_header">Recommended Parenteral Regimen A
            </div>
            <hr/>
            <span class="regimen_text">Cefotetan 2 g IV every 12 hours
            <div id="or">OR</div>Cefoxitin 2 g IV every 6 hours
            <div id="or">
                <hr/>PLUS
                <hr/>
            </div>Doxycycline 100 mg orally or IV every 12 hours
            </span>

        </div>
 <br/>
</p>
<p>
 Because of the pain associated with intravenous infusion, doxycycline should be administered orally when possible. Oral and IV administration of doxycycline provide similar bioavailability.
</p>
<p>
 Parenteral therapy can be discontinued 24 hours after clinical&nbsp;improvement, but oral therapy with doxycycline (100 mg twice a day) should continue to complete 14 days of therapy. When tubo-ovarian abscess is present, clindamycin or metronidazole&nbsp;with doxycycline can be used for continued therapy rather than doxycycline alone because this regimen provides more effective anaerobic coverage.
</p>
<p>
 Limited data are available to support the use of other second- or third-generation cephalosporins (e.g., ceftizoxime, cefotaxime, and ceftriaxone), which also might be effective therapy for PID and could potentially replace cefotetan or cefoxitin. However, these cephalosporins are less active than cefotetan or cefoxitin against anaerobic bacteria.
</p>
<p>


        <!--- Regimens Table below is generated from Python script.  --->
        <div id="table">
            <div id="regimen_header">Recommended Parenteral Regimen B
            </div>
            <hr/>
            <span class="regimen_text">Clindamycin 900 mg IV every 8 hours
            <div id="or">PLUS</div>Gentamicin loading dose IV or IM (2 mg/kg of body weight), followed by a maintenance dose (1.5 mg/kg) every 8 hours. Single daily dosing (3â€“5 mg/kg) can be substituted.
            </span>

        </div>
 <br/>
</p>
<p>
 Although use of a single daily dose of gentamicin has not been evaluated for the treatment of PID, it is efficacious in analogous situations. Parenteral therapy can be discontinued 24 hours after clinical improvement; ongoing oral therapy should consist of doxycycline 100 mg orally twice a day, or clindamycin 450 mg orally four times a day to complete a total of 14 days of therapy. When tubo-ovarian abscess is present, clindamycin should be continued rather than doxycycline, because clindamycin provides more effective anaerobic coverage.
</p>

            </div>
            <script type="text/javascript">

                $('div').live('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackFullGuidelinesPageView("300");
                                                },true);
                });
            </script>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

    